05:55 PM EDT, 09/03/2024 (MT Newswires) -- Zura Bio ( ZURA ) filed a shelf registration statement with the US Securities and Exchange Commission Tuesday covering the potential sale of up to $300 million of ordinary shares, preferred shares, debt securities, warrants and units from time to time in one or more offerings.

This includes up to $125 million of class A shares that may be issued and sold under an agreement with Leerink Partners via at-the-market offerings, according to a regulatory filing.

The company said it plans to use the net proceeds of any offering of securities for working capital and other general corporate purposes.

Price: 4.1700, Change: +0.09, Percent Change: +2.21